The 2021 Q1 Biopharma Confidence Index Data is here. Click here to view the data now

We have exciting data on how industry executives are viewing the Biopharma Industry, where they are confident, where the risks are, and what the outsourcing trends are as we approach 1 year since the start of the pandemic.

Click here to access the data.

REGISTER: The 2021 Q1 BCI Panel Discussion on Thursday, February 25th at 2 pm ET

Kineticos is excited to release the data from the 2021 Q1 BCI and host a panel discussion with Kineticos Experts and Industry Veterans on what the data means, how things have changed since COVID started and how the future looks as more and more get vaccinated. Register now to get early access to the panelists, topics, and other information related to the panel discussion.

Click here to register.

The Biopharma CEO Confidence Index is a forward-looking indicator designed to measure C-suite sentiment and confidence in the biopharma industry’s economy.  Click below to view current and past results.

The BCI is intended to be a forward-looking index designed to measure c-suite and executive leadership sentiment in the biopharma industry asking questions about their confidence levels concerning key issues. We look for the BCI to become a valuable and highly sought-after resource for its key insights across both key industry-related issues and business functions, including:

  • Capital Markets
  • Deal Landscape
  • Mergers and Acquisitions
  • Clinical Development
  • Regulatory Affairs
  • Commercialization
  • Business Model and Workforce